Simsir A, Palacios D, Linehan W M, Merino M J, Abati A
Cytopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Diagn Cytopathol. 2001 May;24(5):328-32. doi: 10.1002/dc.1070.
Loss of heterozygosity (LOH) at the 3p region is found in up to 50% of epithelial ovarian neoplasms. The von Hippel-Lindau (VHL) gene at the 3p25 locus is one of the tumor-suppressor genes located at 3p. The role, if any, of the VHL gene locus is not clear in ovarian carcinogenesis. We analyzed primary and metastatic ovarian clear-cell carcinomas (OCCC) for LOH at 3p25 to determine its frequency and its diagnostic utility as an adjunctive tool in the differential diagnosis of metastatic clear-cell carcinomas. Microdissection followed by single-step DNA extraction and polymerase chain reaction (PCR) amplification, using two polymorphic markers flanking the VHL gene locus, was done on archival histology and cytology samples from 9 patients with metastatic OCCC. Of the informative cases, 43% of the metastatic and 50% of the primary OCCC showed LOH. LOH at the VHL gene locus is not uncommon in clear-cell ovarian carcinoma. LOH at 3p25 in cytologic specimens may be a valuable adjunct in the diagnosis of OCCC metastasis in cytologically equivocal cases. OCCC should enter the differential in clear-cell carcinomas of unknown primary that show LOH at 3p25. Published 2001 Wiley-Liss, Inc.
在高达50%的上皮性卵巢肿瘤中可发现3p区域的杂合性缺失(LOH)。位于3p25位点的von Hippel-Lindau(VHL)基因是位于3p的肿瘤抑制基因之一。VHL基因位点在卵巢癌发生中的作用(如果有)尚不清楚。我们分析了原发性和转移性卵巢透明细胞癌(OCCC)中3p25处的LOH,以确定其频率及其作为转移性透明细胞癌鉴别诊断辅助工具的诊断效用。对9例转移性OCCC患者的存档组织学和细胞学样本进行显微切割,随后进行单步DNA提取和聚合酶链反应(PCR)扩增,使用位于VHL基因位点两侧的两个多态性标记。在信息性病例中,43%的转移性OCCC和50%的原发性OCCC显示出LOH。VHL基因位点的LOH在透明细胞卵巢癌中并不罕见。在细胞学标本中3p25处的LOH可能是在细胞学上模棱两可的病例中诊断OCCC转移的有价值的辅助手段。在3p25处显示LOH的不明原发部位的透明细胞癌的鉴别诊断中应考虑OCCC。2001年由Wiley-Liss公司出版。